Previous Article | Next Article 
Infection and Immunity, June 1999, p. 2916-2919, Vol. 67, No. 6
0019-9567/99/$04.00+0
Genes Influencing Resistance to Coccidioides immitis
and the Interleukin-10 Response Map to Chromosomes 4 and 6 in Mice
Joshua
Fierer,1,2,*
Lorraine
Walls,3
Fred
Wright,4 and
Theo N.
Kirkland1,2
Departments of
Medicine1 and
Pathology,2 Veterans Administration San
Diego Healthcare System and University of California
San Diego
School of Medicine, and Veterans Administration Research
Service,3 San Diego, California, and
Division of Human Cancer Genetics and the Comprehensive
Cancer Center, The Ohio State University, Columbus,
Ohio4
Received 14 January 1999/Returned for modification 11 February
1999/Accepted 25 March 1999
 |
ABSTRACT |
Coccidioidomycosis is a fungal infection that is endemic in the
southwestern United States. Infection is more severe in blacks and
Filipinos, which suggests that there is a genetic basis for susceptibility to this infection in humans. We found that there is also
a difference in resistance to Coccidioides immitis
infection among inbred mouse strains: B6 mice are susceptible, while
DBA/2 mice are resistant (T. N. Kirkland and J. Fierer, Infect.
Immun. 40:912-916, 1983). In this paper we report the results of our efforts to map the genes responsible for resistance to
this infection in mice. Mice were infected by intraperitoneal
inoculation, and 15 days later the numbers of viable
fungi in their lungs and spleens were enumerated. We also determined
the amounts of interleukin-10 mRNA made in the infected lungs.
These three phenotypes were mapped as quantitative traits by
using the 26 available lines of recombinant inbred mice derived
from a cross between B6 and DBA/2 mice. The best associations were
those between the regions near the Lv locus on chromosome 4 and the Tnfr1 locus on chromosome 6. We then infected backcross mice [(B6 × DBA/2) × B6] and confirmed these
associations; 14 of 16 (87%) mice that were heterozygous at both
Lv and Tnfr1 were resistant to infection,
whereas only 4 of 16 (25%) mice that were homozygous B6 at both loci
were resistant. These are the first genetic loci to be associated with
susceptibility to C. immitis, but there may be additional
genes involved in murine resistance to this infection.
 |
INTRODUCTION |
Coccidioidomycosis is one of the
mycoses endemic in the United States. The fungus Coccidioides
immitis grows as a mold in the desert soil in the southwestern
states, and infection is acquired by inhalation of arthroconidia
(8). In the lung the fungus converts to the spherule form,
which is a pathognomonic structure (4, 25). The majority of
infected people develop delayed hypersensitivity manifested by a
positive skin test, and they recover spontaneously (24).
However, 5 to 10% of infections are not self-limited, and in many of
those patients, infections disseminate to extrapulmonary sites
(4). Patients with disseminated infections do not develop a
positive skin test but do make high titers of antibody (16,
23). Thus, it is likely that patients who recover spontaneously
mount Th1 immune responses, whereas the others mount Th2 responses.
Although the risk of progressive (disseminated) infection is relatively
small, it is not equal in all populations. Patients with T-lymphocyte
deficiencies are more susceptible (1, 9). Among previously
healthy people, Filipinos and blacks have 5- to 10-fold higher rates of
disseminated coccidioidomycosis than do Caucasians (3, 6, 15,
22). Even in military populations, where the risk of exposure and
access to medical care are similar for all groups, blacks and Filipinos
have higher rates of disseminated coccidioidomycosis (6, 15,
17). This suggests that there is a genetic basis for
susceptibility to this infection in humans.
In order to try to find an animal model that could be used to study the
genetics of resistance to C. immitis, we infected several
inbred strains of mice (11). We found that DBA/2 mice are
more than 1,000-fold more resistant to intraperitoneal (i.p.) infection
with C. immitis than B6 and BALB/c mice, and that resistance is the dominant phenotype. These results were confirmed by Cox et al.,
who infected mice by the respiratory route (2). We recently
showed that susceptible strains of mice make higher levels of
interleukin-10 (IL-10) and that IL-10-deficient mice are resistant to
infection (5). IL-4-deficient mice are also more resistant, but less so than the IL-10-deficient mice. Magee and Cox also demonstrated that IL-4 impairs the ability of BALB/c mice to resist infection (13).
In this paper we have started to map the genes in mice that determine
resistance to i.p. infection with C. immitis and influence the IL-10 response to infection. We have used a set of recombinant inbred (RI) mice that were derived from a cross between B6
(susceptible) and DBA/2 (resistant) mice (B×D). Each line of RI
mice is completely inbred and is a result of recombination between the
two progenitor strains at the F2 generation, with 18 generations of subsequent inbreeding fixing each locus. Thus, each RI
line is a patchwork of the two progenitors, and at every genetic locus
an RI line has either the B6 or the DBA/2 allele. More than 1,000 loci
have been mapped in each RI line. However, since the progenitor
strains are genetically related to varying degrees, not all alleles
will be polymorphic in any given RI set. The expression of a phenotype (such as resistance to an infection) can be determined in the different RI lines and then compared to the strain distribution pattern
of all known genetic loci in order to look for evidence of linkage.
 |
MATERIALS AND METHODS |
Mice.
Mice were purchased from Jackson Laboratories, Bar
Harbor, Maine, and housed four to a cage with free access to food and
water. The Animal Research Committee at the Veterans
Administration (VA) approved the experiments. After the mice were
infected, they were housed in an isolator with HEPA-filtered air.
Female mice 7 to 12 weeks of age were used in all experiments.
Infection.
Mice were infected i.p. with 500 to 800 CFU of
the RS strain of C. immitis as described previously (5,
27). Mice were sacrificed 15 days later (unless otherwise
stated), and their spleens and left lungs were removed for quantitative
culture on Mycosel agar. The right lungs were used to extract RNA
for cytokine analysis, as previously described. There were 10 RI mice
in each group, and at least 4 B6 and 4 DBA/2 mice were used as controls for each experiment. The experiment was repeated if the infection was
not sufficiently severe in the B6 mice (one or more deaths). The DBA/2
mice were used as the standard for resistance to infection.
Genetic analysis. (i) B×D.
The median number of CFU per
lung was calculated for each B×D line by performing quantitative
cultures of the homogenized lungs. This value was used to determine
linkages with marker loci in the B×D RI lines by using Map Manager QT
(14). We defined resistance to infection as a function of
the number of CFU per lung and performed quantitative trait locus (QTL)
mapping, using Map Manager QTb23. This program does both simple
regression, to find marker loci which are significantly associated with
the quantitative trait, and interval mapping, to identify locations
among mapped marker loci which are candidates for the position of a
QTL. The program calculates a likelihood ratio statistic for the
interval mapping, producing a chi-square statistic at each genomic
position. True genomewide P values were also computed based
on 1,000 random permutations of the phenotypes, with the maximum
logarithm of the odds favoring linkage (LOD) recorded for each permutation.
(ii) Backcross.
(B6 × DBA/2)F1 mice were
bred from parents obtained from Jackson Laboratories, and at the age of
8 weeks they were mated with B6 mice. Female backcross offspring were
infected at the age of 6 to 8 weeks. Each experiment included 10 to 15 backcross mice and 6 females of the F1 and B6 parental
strains as controls. The B6 mice were used to ensure that the inoculum
was adequate in each experiment. Because of experiment-to-experiment
variation in the inoculum, the definition of resistance was normalized
to the F1 controls. Backcross mice were classified as
resistant if the number of CFU per lung was no greater than the highest
value found in an F1 (resistant) control in that
experiment. DNA was prepared from the tail of each animal and used for
genotyping. We purchased PCR primers from Genetics Research
(Huntsville, Ala.) to amplify D4Mit142, a polymorphic SSLP that maps to
within 1 centimorgan (cM) of the Lv gene. We synthesized PCR primers
according to published sequences to amplify the polymorphic region of
the Tnfr1 gene (26). In both cases, the PCR products were
run on 4% agarose gels, and the two alleles were distinguished by
size. Each mouse was classified as homozygous B6 or heterozygous at each locus. The distribution of genotypes was compared by the Fisher
exact test, and we ran a test for a trend in the proportion susceptible
to infection as a function of the number of B6 alleles (7).
 |
RESULTS |
We first compared the time courses of infection in B6 and DBA/2
mice that were infected i.p. with ~500 CFU of arthroconidia (Fig.
1). There was no evidence of infection in
the lungs of either strain from days 10 to 12 after infection, and then
the disease progressed rapidly in B6 mice. B6 mice began to die on day
14 after infection, and only one survived to day 16, whereas all DBA/2
mice survived to day 16. Therefore, for subsequent experiments we chose
day 15 as the time of sacrifice, assuming that this would be the point
of maximum infection in surviving B6 mice, when we would find the
largest difference in numbers of CFU per lung between susceptible and
resistant mice. On day 15 after infection the median number of CFU per
lung was >100 times higher in B6 mice than in DBA/2 mice. However,
there was some overlap between the two groups, and the spread of values
within each group was >2 log units (Fig.
2). This variability was seen both within
experiments and between experiments.

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of the time courses of C. immitis
infection in resistant DBA/2 mice (open circles) and susceptible B6
mice (solid triangles), as measured by quantitative colony counts in
their lungs. Each point represents a single mouse. Dead mice were
assigned 107 CFU/lung, the number recovered from the most
heavily infected live mouse. The dead mice are indicated with a
"d." The one remaining B6 mouse died on day 16 and was necropsied
immediately.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Distribution of values for CFU per lung on day 15 after
infection with ~500 arthroconidia injected i.p. Open bars, values for
DBA/2 mice; solid bars, values for B6 mice. For simplicity, mice with
colony counts between the 0.5 log markers were grouped together into
the next category.
|
|
In Fig. 3 we show the median numbers of
CFU per lung for the 26 RI lines and the two progenitor strains. Four
B×D lines (lines 16, 18, 19, and 28) had median numbers of CFU per
lung that were >10 times the number of CFU found in the susceptible B6
parent, and these strains also had higher mortality rates (data not
shown). In five B×D lines the median numbers of CFU per lung were
<10% of the median number in the resistant DBA/2 strain. Thus,
~25% of the B×D lines were more resistant and 25% were more
susceptible than either parental strain, which suggests that resistance
to C. immitis is a polygenic trait and may be due to two
unlinked loci, and that the B6 strain carries one or more genes that
contribute to resistance. The same distribution was seen among B×D
strains when we analyzed the numbers of CFU per spleen (data not
shown). Therefore, we analyzed these phenotypes as quantitative or
continuous traits. We used Map Manager QTb23 to find genetic loci
that were associated with these phenotypes in B×D lines. We
identified the two loci that had the highest associations with
both phenotypes (CFU per lung and CFU per spleen): Tnfr1 (p55) on
chromosome 6 and Lv (aminolevulinate dehydratase)
(10) on chromosome 4 (Table 1). Using the geometric mean rather than
the median values for CFU per lung or per spleen to define the
QTL phenotypes did not appreciably change the results. We previously
used the designation Cms for the gene that is responsible
for resistance to C. immitis (12), so we called
the resistance loci on chromosomes 4 and 6 Cms1 and
Cms2, respectively. The permutation-based P
values for these associations are not as striking because they are true genomewide values.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Variation in severity of C. immitis infection
among 26 B×D RI lines. Each point is the median value for CFU per lung
for each RI line. There were at least 10 mice in each group, except for
B×D group 13, which had only 4 mice because of limited availability of
this line. Values for the control B6 and DBA/2 mice are shown for
comparison.
|
|
The associations of these two loci with the susceptibility phenotype
were not strong enough to exclude the possibility of a false-positive
association (type 1 error). However, the number of CFU per lung, the
number of CFU per spleen, and the IL-10 mRNA level all mapped to the
same regions on chromosomes 4 and 6. This encouraged us to conduct
further experiments to try to confirm these linkages.
Because resistance to C. immitis is a dominant phenotype
(11), we backcrossed (B6 × DBA/2)F1 × B6
mice and tested all the progeny for resistance to C. immitis. As shown in Table 2, 14 of
16 mice that were heterozygous at both loci were resistant to
infection, while only 4 of 16 that were homozygous B6 at both loci were
resistant (P = 0.0012 by the Fisher exact test). Note that about 50% of the mice that were heterozygous at either locus were
resistant. A chi-square test for a linear trend in the table (with
singly heterozygous mice combined) was highly significant (X2 = 12.52; P = 0.0004) (7).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Relationship between resistance to infection and the
genotype of Tnfr1 and Lv in (B6 × DBA/2) × B6 backcross mice
|
|
Because we know that susceptible strains of inbred mice make high
levels of IL-10 after infection and that IL-10 knockout (KO) mice
are resistant to C. immitis (5), we reasoned that the genetic control over infection was at least in part
due to genetic controls on the IL-10 response to
coccidioidomycosis. As shown in Fig.
4, there was a strong correlation
(r = 0.77) between the median number of C. immitis CFU per lung and the amount of IL-10 mRNA in the
lung. Therefore, it was not unexpected that when we mapped
the IL-10 response as a QTL, we found linkages with the same two loci
near Tnfr1 and Lv (Table 1).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Correlation between median values for CFU and IL-10 mRNA
levels in 26 B×D RI lines. IL-10 mRNA was measured by a quantitative
reverse transcription-PCR assay, pooling equal amounts of RNA from four
mice in each group. Each point is a single RI line (r = 0.77).
|
|
 |
DISCUSSION |
We have begun mapping the genes responsible for genetic resistance
to C. immitis in mice. When RI lines were first
conceived of, it was with the idea of using them to analyze complex
phenotypes (19). Initially we used the B×D RI set for
mapping, which has both advantages and disadvantages. The
advantages are that 26 B×D lines are available from Jackson
Laboratories, many genetic markers have already been mapped in this set
of mice, and the data set can be analyzed with available statistical
programs. The limitation of the B×D set is that it contains only 26 RI
lines, which means that one is testing only 26 individual crosses. As a
result, it is difficult to map a multigenic trait with a high degree of
assurance. The more genes that contribute to a phenotype, the more
subjects are needed to accurately map the QTL (19).
Another advantage of RI lines is that the mice are inbred, and so
multiple genetically identical subjects can be tested. This allowed us
to assign a phenotype to the RI lines (median CFU per lung or per
spleen 15 days after i.p. infection) more precisely than would have
been possible for individual mice. This was particularly important for
analyzing resistance to this infection, because, as shown in Fig. 2,
there was even variability in the number of CFU per lung in the two
parental strains. When there is overlap in the distribution of
the phenotype (number of CFU per lung in this case), it becomes more
difficult to analyze QTL. Some of the variability in colony counts
could have been due to the biology of replication of the fungus. In
tissue, C. immitis grows as spherules that mature to contain
thousands of endospores. A single intact spherule will give rise to one
colony when cultured in vitro, as will each endospore. Therefore, the
rupture of a spherule to release endospores can raise colony counts
substantially. This probably also accounts for the rapidity with which
the infection progresses in susceptible B6 mice (Fig. 1). Because the
growth of the fungus is so dynamic, it is possible that small
variations in the inoculum could result in large variations in colony
counts 15 days after infection, which could also account for some of the variability. We also recognize that we are mapping the genes that
determine the numbers of fungi in the lungs and spleens after i.p.
infection, which may not always be the same as the susceptibility to
infection measured in other tissues, or susceptibility to respiratory infection.
Despite these difficulties with mapping in the B×D lines, we
identified a region on chromosome 6 near Tnfr1 and another
on chromosome 4 near Lv that were linked in B×D mice to
resistance to infection and to IL-10 response to infection with
C. immitis. The LOD scores for these linkages were not high
enough to exclude the possibility that these were chance associations,
but the same two loci were identified for each of the three phenotypes.
We then confirmed those linkages by infecting (B6 × DBA/2)F1 × B6 backcross mice. Eighty-seven percent (14 of
16) of the mice that were heterozygous at both Tnfr1r and
Lv were resistant to infection, whereas only 25% (4 of 16)
of the mice that were B6 at both loci were resistant. Mice that were
heterozygous at only one of the two loci showed intermediate
resistance, a result that is consistent with the additive effect of the
two loci. Taken together, we believe we have good evidence that there
are genes on chromosomes 4 and 6 that influence resistance to coccidioidomycosis.
We have recently reported that DBA/2 mice make less IL-10 in response
to infection with C. immitis than do three susceptible inbred strains (B6, BALB/c, and CAST/Ei) (5). We also showed that IL-10 KO mice are resistant to C. immitis. In this
study we showed that in the 26 B×D lines there was a strong
correlation between the amount of IL-10 mRNA made in the lungs and the
number of fungi growing in the lungs on day 15 after infection (Fig. 4). These results with the RI lines give more weight to the association between IL-10 production and susceptibility to infection.
It has long been recognized that there is great variability in the
severity of coccidioidomycosis, ranging from asymptomatic infection to
overwhelming disease (4, 8). Such variation could be due to
differences in the dose or the virulence of a pathogen, prior immunity,
or intercurrent illnesses that affect resistance to infection, but in
many cases there is no apparent explanation for the variability in
the severity of the disease. It is often assumed that some of the
variability is due to genetic differences in the hosts, but few
genes, that make humans or animals susceptible to
specific pathogens have been identified (20).
The two loci that we have identified are almost certainly not the only
genes involved in determining resistance to C. immitis. BALB/c and B6 mice are both highly susceptible to C. immitis, and the F1 generation from these two strains
is also susceptible, so they do not complement each other's
defects (11). However, in separate experiments we found
that (CAST/Ei × B6)F1 mice were more resistant to
C. immitis than either parent strain (they complement each
other), evidence that B6 mice have at least one beneficial allele
(5a). This is reminiscent of the genetics of resistance to
salmonella infections in mice, in which the Nramp1 gene
plays a dominant role (21). However, Sebastiani et al.
recently reported that B6 mice, which are susceptible because they
carry a mutant Nramp1, have at least two
Salmonella resistance genes that were detected because B6
mice complemented another susceptible strain (18). A
similar mapping strategy may reveal additional genes in B6 mice for
resistance to C. immitis.
 |
ACKNOWLEDGMENTS |
This work was supported in part by the VA Research Service
and NIH PO1AI37232, and by NIH P30CA16508 and RO1gm58934 (F. Wright).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Infectious
Diseases Section (111F), VA San Diego Healthcare System, 3350 La Jolla
Village Dr., San Diego, CA 92161. Phone: (619) 552-7446. Fax: (619)
552-4398. E-mail: jfierer{at}ucsd.edu.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Ampel, N. M.,
C. L. Dols, and J. N. Galgiani.
1993.
Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area.
Am. J. Med.
94:235-240[Medline].
|
| 2.
|
Cox, R. A.,
W. Kennell,
L. Boncyk, and J. W. Murphy.
1988.
Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.
Infect. Immun.
56:13-17[Abstract/Free Full Text].
|
| 3.
|
Cox, R. A.,
J. R. Vivas,
A. Gross,
G. Lecara,
E. Miller, and E. Brummer.
1976.
In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immunologic responses of persons with primary, asymptomatic infections.
Am. Rev. Respir. Dis.
114:937-943[Medline].
|
| 4.
|
Drutz, D. J., and A. Catanzaro.
1978.
Coccidioidomycosis. Part I.
Am. Rev. Respir. Dis.
117:559-583[Medline].
|
| 5.
|
Fierer, J.,
L. Walls,
L. Eckmann,
T. Yamamoto, and T. N. Kirkland.
1998.
Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis.
Infect. Immun.
66:4397-4402[Abstract/Free Full Text].
|
| 5a.
| Fierer, J. Unpublished data.
|
| 6.
|
Fischl, M. A.,
G. M. Dickinson,
C. Sinave,
A. E. Pitchenik, and T. J. Cleary.
1986.
Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome.
Arch. Intern. Med.
146:113-115[Abstract].
|
| 7.
|
Fleiss, J. L.
1981.
Statistical methods for rates and proportions.
Wiley, New York, N.Y.
|
| 8.
|
Galgiani, J. N.
1993.
Coccidioidomycosis.
West. J. Med.
159:153-171[Medline].
|
| 9.
|
Hall, K. A.,
G. K. Sethi,
L. J. Rosado,
J. D. Martinez,
C. L. Huston, and J. G. Copeland.
1993.
Coccidioidomycosis and heart transplantation.
J. Heart Lung Transplant.
12:525-526[Medline].
|
| 10.
|
Hutton, J. J., and D. L. Coleman.
1969.
Linkage analyses using biochemical variants in mice. II. Levulinate dehydratase and autosomal glucose 6-phosphate dehydrogenase.
Biochem. Genet.
3:517-523[Medline].
|
| 11.
|
Kirkland, T. N., and J. Fierer.
1983.
Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection.
Infect. Immun.
40:912-916[Abstract/Free Full Text].
|
| 12.
|
Kirkland, T. N., and J. Fierer.
1985.
Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance.
J. Immunol.
135:548-552[Abstract].
|
| 13.
|
Magee, D. M., and R. A. Cox.
1995.
Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis.
Infect. Immun.
63:3514-3519[Abstract].
|
| 14.
|
Manley, K. F.
1993.
A Macintosh program for storage and analysis of experimental genetic mapping data.
Mamm. Genome
4:303-313[Medline].
|
| 15.
|
Pappagianis, D.
1988.
Epidemiology of coccidioidomycosis, p. 199-238.
In
M. R. McGinnis (ed.), Current topics in medical mycology. Springer-Verlag, New York, N.Y.
|
| 16.
|
Pappagianis, D., and B. L. Zimmer.
1990.
Serology of coccidioidomycosis.
Clin. Microbiol. Rev.
3:247-268[Abstract/Free Full Text].
|
| 17.
|
Rush, W. L.,
D. P. Dooley,
S. P. Blatt, and D. M. Drehner.
1993.
Coccidioidomycosis: a persistent threat to deployed populations.
Aviat. Space Environ. Med.
64:653-657[Medline].
|
| 18.
|
Sebastiani, G.,
L. Olien,
S. Gauthier,
E. Skamene,
K. Morgan,
P. Gros, and D. Malo.
1998.
Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice.
Genomics
47:180-186[Medline].
|
| 19.
|
Silver, L. M.
1995.
Classical linkage analysis and mapping panels, p. 195-263.
In
L. M. Silver (ed.), Mouse genetics. Concepts and applications. Oxford University Press, New York, N.Y.
|
| 20.
|
Skamene, E.
1983.
Genetic regulation of host resistance to bacterial infection.
Rev. Infect. Dis.
5(Suppl. 4):S823-S831.
|
| 21.
|
Skamene, E.,
P. Gros,
A. Forget,
P. A. L. Kongshavn,
C. St. Charles, and B. A. Taylor.
1982.
Genetic regulation of resistance to intracellular pathogens.
Nature
297:506-510[Medline].
|
| 22.
|
Smith, C. E.,
R. R. Beard,
E. G. Whiting, and H. G. Rosenberger.
1946.
Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases.
Am. J. Public Health
36:1394-1402.
|
| 23.
|
Smith, C. E.,
M. T. Saito, and S. A. Simons.
1956.
Pattern of 39,500 serologic tests in coccidioidomycosis.
JAMA
160:546-552.
|
| 24.
|
Stevens, D. A.,
H. B. Levine, and D. R. TenEyck.
1974.
Dermal sensitivity to different doses of spherulin and coccidioidin.
Chest
65:530-533[Abstract/Free Full Text].
|
| 25.
|
Sun, S. H.,
S. S. Sekhon, and M. Huppert.
1979.
Electron microscopic studies of saprobic and parasitic forms of Coccidioides immitis.
Sabouraudia
17:265-273[Medline].
|
| 26.
|
Takao, S.,
K. Mykytyn, and C. O. Jacob.
1993.
Novel DNA polymorphism in the mouse tumor necrosis factor receptors type 1 and type 2.
Immunogenetics
37:199-203[Medline].
|
| 27.
|
Walch, H. A., and A. Kalvoda.
1971.
Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Sabouraudia
9:173-184[Medline].
|
Infection and Immunity, June 1999, p. 2916-2919, Vol. 67, No. 6
0019-9567/99/$04.00+0
This article has been cited by other articles:
-
Jimenez, M. d. P., Walls, L., Fierer, J.
(2006). High Levels of Interleukin-10 Impair Resistance to Pulmonary Coccidioidomycosis in Mice in Part through Control of Nitric Oxide Synthase 2 Expression.. Infect. Immun.
74: 3387-3395
[Abstract]
[Full Text]
-
Viriyakosol, S., Fierer, J., Brown, G. D., Kirkland, T. N.
(2005). Innate Immunity to the Pathogenic Fungus Coccidioides posadasii Is Dependent on Toll-Like Receptor 2 and Dectin-1. Infect. Immun.
73: 1553-1560
[Abstract]
[Full Text]
-
Cox, R. A., Magee, D. M.
(2004). Coccidioidomycosis: Host Response and Vaccine Development. Clin. Microbiol. Rev.
17: 804-839
[Abstract]
[Full Text]